Jonathan Krinsky, chief market technician at BTIG, joins CNBC's 'The Exchange to discuss his outlook on stocks for 2025, what ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

BTIG raised the firm’s price target on Glaukos (GKOS) to $157 from $149 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical Technology names ...

BTIG's Krinsky noted that while equity markets in the first half of 2024 were fueled mostly by the surge in mega-cap names ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Glaukos (GKOS – Research Report), with a price target of ...

BTIG Research has recently reduced FiscalNote Holdings Inc (NOTE) stock to Neutral rating, as announced on November 15, 2023, according to Finviz. Earlier, on July 26, 2023, B. Riley Securities had ...

FREYR Battery Inc (FREY) stock saw a decline, ending the day at $2.58 which represents a decrease of $-0.12 or -4.44% from the prior close of $2.7. The stock opened at $2.71 and touched a low of $2.45 ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Staar Surgical (STAA – Research Report) today and set a price target of $39.00. The ...

BTIG said it would be cautious on Apple's (NASDAQ:AAPL) stock heading into January 2025. Analyst Jonathan Krinsky said the ...

Research analysts at StockNews.com started coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage ...

BTIG analyst Jeet Mukherjee initiated coverage of Arvinas (ARVN) with a Buy rating and $69 price target The company’s lead program, vepdegestrant, is a potent ER degrader for being developed for ...

According to a BTIG strategist, the rally in the index was rejected from the previous support trendline and even though there are still four days left for the Santa Claus rally to deliver gains, there ...